In a different model, the injection of CpG-activated pDCs after a tumor challenge led to a significant delay in the growth of B16 melanoma and MCA205 sarcoma tumors, and induced the recruitment of antigen-specific CD8+ T cells and activated NK cells into tumors by a mechanism dependent on endogenous cDCs and NK cells. Here, CD8A is linked to melanoma.